On Friday, Ocugen Inc (NASDAQ: OCGN) opened higher 4.20% from the last session, before settling in for the closing price of $0.91. Price fluctuations for OCGN have ranged from $0.35 to $2.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 8.52% over the past five years. Company’s average yearly earnings per share was noted 18.27% at the time writing. With a float of $283.71 million, this company’s outstanding shares have now reached $287.86 million.
Let’s look at the performance matrix of the company that is accounted for 65 employees. In terms of profitability, gross margin is 86.41%, operating margin of -631.33%, and the pretax margin is -620.91%.
Ocugen Inc (OCGN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ocugen Inc is 1.44%, while institutional ownership is 23.93%. The most recent insider transaction that took place on Aug 16 ’24, was worth 145,905.
Ocugen Inc (OCGN) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.06 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.07) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.27% per share during the next fiscal year.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
Check out the current performance indicators for Ocugen Inc (OCGN). In the past quarter, the stock posted a quick ratio of 1.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 79.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.18, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.26 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
Ocugen Inc (NASDAQ: OCGN) saw its 5-day average volume 3.92 million, a negative change from its year-to-date volume of 6.19 million. As of the previous 9 days, the stock’s Stochastic %D was 36.51%. Additionally, its Average True Range was 0.07.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 5.45%, which indicates a significant decrease from 39.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.01% in the past 14 days, which was lower than the 72.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0638, while its 200-day Moving Average is $1.2628. Nevertheless, the first resistance level for the watch stands at $0.9654 in the near term. At $0.9815, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.0065. If the price goes on to break the first support level at $0.9243, it is likely to go to the next support level at $0.8993. The third support level lies at $0.8832 if the price breaches the second support level.
Ocugen Inc (NASDAQ: OCGN) Key Stats
There are currently 287,858K shares outstanding in the company with a market cap of 284.75 million. Presently, the company’s annual sales total 6,040 K according to its annual income of -63,080 K. Last quarter, the company’s sales amounted to 1,140 K and its income totaled -15,280 K.
